Copyright Reports & Markets. All rights reserved.

Global Ligand Binding Assay Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Ligand Binding Assay Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Radioactive
      • 1.4.3 Non-radioactive
    • 1.5 Market by Application
      • 1.5.1 Global Ligand Binding Assay Market Share by Application (2014-2025)
      • 1.5.2 Biomedical Research
      • 1.5.3 Drug Discovery
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Ligand Binding Assay Market Size
    • 2.2 Ligand Binding Assay Growth Trends by Regions
      • 2.2.1 Ligand Binding Assay Market Size by Regions (2014-2025)
      • 2.2.2 Ligand Binding Assay Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Ligand Binding Assay Market Size by by Players
      • 3.1.1 Global Ligand Binding Assay Revenue by by Players (2014-2019)
      • 3.1.2 Global Ligand Binding Assay Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Ligand Binding Assay Market Concentration Ratio (CR5 and HHI)
    • 3.2 Ligand Binding Assay Key Players Head office and Area Served
    • 3.3 Key Players Ligand Binding Assay Product/Solution/Service
    • 3.4 Date of Enter into Ligand Binding Assay Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Ligand Binding Assay Market Size by Type (2014-2019)
    • 4.2 Global Ligand Binding Assay Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Ligand Binding Assay Market Size (2014-2019)
    • 5.2 Ligand Binding Assay Key Players in United States
    • 5.3 United States Ligand Binding Assay Market Size by Type
    • 5.4 United States Ligand Binding Assay Market Size by Application

    6 Europe

    • 6.1 Europe Ligand Binding Assay Market Size (2014-2019)
    • 6.2 Ligand Binding Assay Key Players in Europe
    • 6.3 Europe Ligand Binding Assay Market Size by Type
    • 6.4 Europe Ligand Binding Assay Market Size by Application

    7 China

    • 7.1 China Ligand Binding Assay Market Size (2014-2019)
    • 7.2 Ligand Binding Assay Key Players in China
    • 7.3 China Ligand Binding Assay Market Size by Type
    • 7.4 China Ligand Binding Assay Market Size by Application

    8 Japan

    • 8.1 Japan Ligand Binding Assay Market Size (2014-2019)
    • 8.2 Ligand Binding Assay Key Players in Japan
    • 8.3 Japan Ligand Binding Assay Market Size by Type
    • 8.4 Japan Ligand Binding Assay Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Ligand Binding Assay Market Size (2014-2019)
    • 9.2 Ligand Binding Assay Key Players in Southeast Asia
    • 9.3 Southeast Asia Ligand Binding Assay Market Size by Type
    • 9.4 Southeast Asia Ligand Binding Assay Market Size by Application

    10 India

    • 10.1 India Ligand Binding Assay Market Size (2014-2019)
    • 10.2 Ligand Binding Assay Key Players in India
    • 10.3 India Ligand Binding Assay Market Size by Type
    • 10.4 India Ligand Binding Assay Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Ligand Binding Assay Market Size (2014-2019)
    • 11.2 Ligand Binding Assay Key Players in Central & South America
    • 11.3 Central & South America Ligand Binding Assay Market Size by Type
    • 11.4 Central & South America Ligand Binding Assay Market Size by Application

    12 International Players Profiles

    • 12.1 Sygnature Discovery
      • 12.1.1 Sygnature Discovery Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Ligand Binding Assay Introduction
      • 12.1.4 Sygnature Discovery Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.1.5 Sygnature Discovery Recent Development
    • 12.2 Shanghai Medicilon Inc
      • 12.2.1 Shanghai Medicilon Inc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Ligand Binding Assay Introduction
      • 12.2.4 Shanghai Medicilon Inc Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.2.5 Shanghai Medicilon Inc Recent Development
    • 12.3 Intertek Group plc
      • 12.3.1 Intertek Group plc Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Ligand Binding Assay Introduction
      • 12.3.4 Intertek Group plc Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.3.5 Intertek Group plc Recent Development
    • 12.4 PerkinElmer Inc
      • 12.4.1 PerkinElmer Inc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Ligand Binding Assay Introduction
      • 12.4.4 PerkinElmer Inc Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.4.5 PerkinElmer Inc Recent Development
    • 12.5 Charles River
      • 12.5.1 Charles River Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Ligand Binding Assay Introduction
      • 12.5.4 Charles River Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.5.5 Charles River Recent Development
    • 12.6 Alliance Pharma
      • 12.6.1 Alliance Pharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Ligand Binding Assay Introduction
      • 12.6.4 Alliance Pharma Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.6.5 Alliance Pharma Recent Development
    • 12.7 Eurofins Discovery
      • 12.7.1 Eurofins Discovery Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Ligand Binding Assay Introduction
      • 12.7.4 Eurofins Discovery Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.7.5 Eurofins Discovery Recent Development
    • 12.8 Creative Biogene
      • 12.8.1 Creative Biogene Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Ligand Binding Assay Introduction
      • 12.8.4 Creative Biogene Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.8.5 Creative Biogene Recent Development
    • 12.9 IBR Inc
      • 12.9.1 IBR Inc Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Ligand Binding Assay Introduction
      • 12.9.4 IBR Inc Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.9.5 IBR Inc Recent Development
    • 12.10 LGC Limited
      • 12.10.1 LGC Limited Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Ligand Binding Assay Introduction
      • 12.10.4 LGC Limited Revenue in Ligand Binding Assay Business (2014-2019)
      • 12.10.5 LGC Limited Recent Development
    • 12.11 Accelero Bioanalytics GmbH
    • 12.12 Gifford Bioscience Limited
    • 12.13 GE Healthcare
    • 12.14 Antigen Discovery Inc

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Ligand binding assays (LBA) are analytical procedures to quantify an analyte (macromolecule) based on its affinity for a ligand, including but not limited to antibodies, antigens, receptors, oligonucleotides and peptides.
      In 2018, the global Ligand Binding Assay market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Ligand Binding Assay status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ligand Binding Assay development in United States, Europe and China.

      The key players covered in this study
      Sygnature Discovery
      Shanghai Medicilon Inc
      Intertek Group plc
      PerkinElmer Inc
      Charles River
      Alliance Pharma
      Eurofins Discovery
      Creative Biogene
      IBR Inc
      LGC Limited
      Accelero Bioanalytics GmbH
      Gifford Bioscience Limited
      GE Healthcare
      Antigen Discovery Inc

      Market segment by Type, the product can be split into
      Radioactive
      Non-radioactive

      Market segment by Application, split into
      Biomedical Research
      Drug Discovery
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Ligand Binding Assay status, future forecast, growth opportunity, key market and key players.
      To present the Ligand Binding Assay development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Ligand Binding Assay are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now